{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T17:42:10Z","timestamp":1784310130893,"version":"3.55.0"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"theEugin Clinic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,1]]},"abstract":"Abstract<\/jats:title>\n \n STUDY QUESTION<\/jats:title>\n Does extending vaginal progesterone administration from 5\u20136 days improve pregnancy outcomes in Day 6 (D6) frozen embryo transfers (FETs) in oocyte donation cycles?<\/jats:p>\n <\/jats:sec>\n \n SUMMARY ANSWER<\/jats:title>\n Prolonging the time of vaginal progesterone supplementation does not improve pregnancy outcomes after D6 FETs in oocyte recipients.<\/jats:p>\n <\/jats:sec>\n \n WHAT IS KNOWN ALREADY<\/jats:title>\n Progesterone is critical for endometrial preparation prior to embryo transfer, but the optimal duration of administration remains unclear. D6 blastocysts are associated with poorer clinical outcomes compared to Day 5 (D5) blastocysts, potentially due to either intrinsic limitations in implantation capacity or a shifted window of implantation (WOI). Extending progesterone administration has been hypothesized to optimize the WOI for D6 blastocysts.<\/jats:p>\n <\/jats:sec>\n \n STUDY DESIGN, SIZE, DURATION<\/jats:title>\n This retrospective cohort study included 485 FETs performed in 420 oocyte donation recipients, conducted from January 2020 to December 2023 in a single IVF center. Participants were divided into two groups based on the duration of progesterone supplementation: 5 days (P\u2009+\u20095, n\u2009=\u2009282) and 6 days (P\u2009+\u20096, n\u2009=\u2009203).<\/jats:p>\n <\/jats:sec>\n \n PARTICIPANTS\/MATERIALS, SETTING, METHODS<\/jats:title>\n The study involved oocyte recipients undergoing single D6 blastocyst transfer following endometrial preparation with vaginal progesterone (800\u2009mg\/day). Outcomes were analyzed using univariate and multivariate tests, including logistic regression adjusted for estrogen type and endometrial thickness.<\/jats:p>\n <\/jats:sec>\n \n MAIN RESULTS AND THE ROLE OF CHANCE<\/jats:title>\n Mean recipient age (\u00b1SD) was 43.5 (\u00b14.24) years, mean BMI was 25.1, and mean endometrial thickness was 9.6\u2009mm on the day of transfer. Good-quality blastocysts accounted for 35% of all transfers. Clinical outcomes, including biochemical (26.24% vs 26.60%, P\u2009=\u20091.00), clinical (21.99% vs 20.69%, P\u2009=\u20090.83), and ongoing pregnancy (14.54% vs 13.30%, P\u2009=\u20090.79), as well as live birth (14.18% vs 10.66%, P\u2009=\u20090.27) and miscarriage rates (7.45% vs 7.39%, P\u2009=\u20091.00), were all similar between 5 and 6 days of progesterone supplementation, respectively. Adjusted analyses confirmed these findings.<\/jats:p>\n <\/jats:sec>\n \n LIMITATIONS, REASONS FOR CAUTION<\/jats:title>\n The retrospective design warrants careful interpretation. Results are specific to vaginal progesterone in oocyte donation cycles and may not apply to other populations or progesterone delivery methods. Additionally, the D6 embryos analyzed were those that did not reach blastocyst by Day 5 (delayed, poor-prognosis, and typically transferred last), which likely biases outcomes toward lower live birth rates.<\/jats:p>\n <\/jats:sec>\n \n WIDER IMPLICATIONS OF THE FINDINGS<\/jats:title>\n Compromised outcomes following D6 FETs compared to those of D5 blastocysts, likely reflect the intrinsic limitations of slow-developing embryos rather than a misaligned WOI. As prolonged progesterone exposure did not improve outcomes, the WOI may be broader than previously assumed, particularly in oocyte donation programs, where superior embryo quality may mitigate synchronization drawbacks.<\/jats:p>\n <\/jats:sec>\n \n STUDY FUNDING\/COMPETING INTEREST(S)<\/jats:title>\n This study was internally funded by the Eugin Clinic, with no external sponsorship. The authors declare no competing interests.<\/jats:p>\n <\/jats:sec>\n \n TRIAL REGISTRATION NUMBER<\/jats:title>\n NA<\/jats:p>\n <\/jats:sec>","DOI":"10.1093\/humrep\/deaf205","type":"journal-article","created":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T03:48:47Z","timestamp":1762660127000},"page":"86-92","source":"Crossref","is-referenced-by-count":2,"title":["Prolonged vaginal progesterone supplementation does not improve outcomes for Day 6 frozen blastocyst transfers in oocyte donation cycles"],"prefix":"10.1093","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-3474-9426","authenticated-orcid":false,"given":"A","family":"Bl\u00e1zquez","sequence":"first","affiliation":[{"name":"Eugin Clinic Department of Reproductive Medicine, , Barcelona,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3461-6404","authenticated-orcid":false,"given":"I","family":"Miguel-Escalada","sequence":"additional","affiliation":[{"name":"Eugin Group Department of Reproductive Medicine, , Barcelona,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Portas-G\u00f3mez","sequence":"additional","affiliation":[{"name":"Eugin Group Department of Reproductive Medicine, , Barcelona,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J J","family":"Guill\u00e9n-Qu\u00edlez","sequence":"additional","affiliation":[{"name":"Eugin Clinic Department of Reproductive Medicine, , Barcelona,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Matar\u00f3","sequence":"additional","affiliation":[{"name":"Eugin Clinic Department of Reproductive Medicine, , Barcelona,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9657-0611","authenticated-orcid":false,"given":"M","family":"Popovic","sequence":"additional","affiliation":[{"name":"Eugin Group Department of Reproductive Medicine, , Barcelona,","place":["Spain"]},{"name":"Department of Reproductive Medicine, Ghent University Hospital , Ghent,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Rodr\u00edguez-Aranda","sequence":"additional","affiliation":[{"name":"Eugin Group Department of Reproductive Medicine, , Barcelona,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,11,5]]},"reference":[{"key":"2026010600515950800_deaf205-B1","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1055\/a-1213-9164","article-title":"Impact of transferring a poor quality embryo along with a good quality embryo on pregnancy outcomes in IVF\/ICSI cycles: a retrospective study","volume":"80","author":"Aldemir","year":"2020","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"2026010600515950800_deaf205-B2","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1093\/humrep\/dez163","article-title":"Day 5 versus Day 6 blastocyst transfers: a systematic review and meta-analysis of clinical outcomes","volume":"34","author":"Bourdon","year":"2019","journal-title":"Hum Reprod"},{"key":"2026010600515950800_deaf205-B3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13039-015-0117-8","article-title":"Assessment of aneuploidy formation in human blastocysts resulting from cryopreserved donor eggs","volume":"8","author":"Deng","year":"2015","journal-title":"Mol Cytogenet"},{"key":"2026010600515950800_deaf205-B4","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s10815-007-9115-z","article-title":"Pregnancy outcome and live birth after IVF and ICSI according to embryo quality","volume":"24","author":"Fauque","year":"2007","journal-title":"J Assist Reprod Genet"},{"key":"2026010600515950800_deaf205-B5","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s10815-015-0492-4","article-title":"Assessment of aneuploidy formation in human blastocysts resulting from donated eggs and the necessity of the embryos for aneuploidy screening","volume":"32","author":"Haddad","year":"2015","journal-title":"J Assist Reprod Genet"},{"key":"2026010600515950800_deaf205-B7","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12884-023-05415-w","article-title":"Comparison of clinical outcomes for different morphological scores of D5 and D6 blastocysts in the frozen-thawed cycle","volume":"23","author":"Jiang","year":"2023","journal-title":"BMC Pregnancy Childbirth"},{"key":"2026010600515950800_deaf205-B8","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.fertnstert.2019.02.009","article-title":"What exactly is endometrial receptivity?","volume":"111","author":"Lessey","year":"2019","journal-title":"Fertil Steril"},{"key":"2026010600515950800_deaf205-B9","doi-asserted-by":"publisher","first-page":"973624","DOI":"10.3389\/fendo.2023.973624","article-title":"Microbiota: a potential orchestrator of antidiabetic therapy","volume":"14","author":"Liu","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2026010600515950800_deaf205-B10","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1093\/humrep\/dex285","article-title":"Frozen embryo transfer: a review on the optimal endometrial preparation and timing","volume":"32","author":"Mackens","year":"2017","journal-title":"Hum Reprod"},{"key":"2026010600515950800_deaf205-B11","doi-asserted-by":"publisher","first-page":"e340","DOI":"10.1016\/j.fertnstert.2015.07.1059","article-title":"How wide is the uterine implantation window?","volume":"104","author":"McCulloh","year":"2015","journal-title":"Fertil Steril"},{"key":"2026010600515950800_deaf205-B12","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1093\/humrep\/dead213","article-title":"Implicit bias in diagnosing mosaicism amongst preimplantation genetic testing providers: results from a multicenter study of 36 395 blastocysts","volume":"39","author":"Popovic","year":"2024","journal-title":"Hum Reprod"},{"key":"2026010600515950800_deaf205-B13","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.fertnstert.2024.04.013","article-title":"The use of preimplantation genetic testing for aneuploidy: a committee opinion","volume":"122","author":"Practice Committees of the American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology","year":"2024","journal-title":"Fertil Steril"},{"key":"2026010600515950800_deaf205-B14","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.fertnstert.2020.03.017","article-title":"Frozen-warmed blastocyst transfer after 6 or 7 days of progesterone administration: impact on live birth rate in hormone replacement therapy cycles","volume":"114","author":"Roelens","year":"2020","journal-title":"Fertil Steril"},{"key":"2026010600515950800_deaf205-B15","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.fertnstert.2006.08.092","article-title":"Contrasting patterns in in vitro fertilization pregnancy rates among fresh autologous, fresh oocyte donor, and cryopreserved cycles with the use of day 5 or day 6 blastocysts may reflect differences in embryo-endometrium synchrony","volume":"89","author":"Shapiro","year":"2008","journal-title":"Fertil Steril"},{"key":"2026010600515950800_deaf205-B16","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1080\/09513590.2017.1318376","article-title":"Vitrified-warmed blastocyst transfer on the 5th or 7th day of progesterone supplementation in an artificial cycle: a randomised controlled trial","volume":"33","author":"van de Vijver","year":"2017","journal-title":"Gynecol Endocrinol"},{"key":"2026010600515950800_deaf205-B17","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1056\/NEJM199906103402304","article-title":"Time of implantation of the conceptus and loss of pregnancy","volume":"340","author":"Wilcox","year":"1999","journal-title":"N Engl J Med"},{"key":"2026010600515950800_deaf205-B18","doi-asserted-by":"publisher","first-page":"565","DOI":"10.4236\/ijcm.2017.811053","article-title":"Comparison of pregnancy outcomes of high-quality D5- and D6-blastocyst transfer in hormone-replacement frozen-thawed cycles","volume":"08","author":"Xing","year":"2017","journal-title":"Int J Clin Med"},{"key":"2026010600515950800_deaf205-B19","doi-asserted-by":"publisher","first-page":"706427","DOI":"10.3389\/fendo.2021.706427","article-title":"Live birth rate of frozen-thawed single blastocyst transfer after 6 or 7 days of progesterone administration in hormone replacement therapy cycles: a propensity score-matched cohort study","volume":"12","author":"Yang","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2026010600515950800_deaf205-B20","doi-asserted-by":"publisher","first-page":"10715","DOI":"10.1038\/s41598-021-90238-y","article-title":"Day 5 vitrified blastocyst transfer versus day 6 vitrified blastocyst transfer in oocyte donation program","volume":"11","author":"Yerushalmi","year":"2021","journal-title":"Sci Rep"},{"key":"2026010600515950800_deaf205-B21","doi-asserted-by":"publisher","first-page":"63","DOI":"10.5653\/cerm.2022.05540","article-title":"The pregnancy outcomes of day-5 poor-quality and day-6 high-quality blastocysts in single blastocyst transfer cycles","volume":"50","author":"Zhang","year":"2023","journal-title":"Clin Exp Reprod Med"},{"key":"2026010600515950800_deaf205-B22","doi-asserted-by":"publisher","first-page":"104307","DOI":"10.1016\/j.rbmo.2024.104307","article-title":"Impact of different progesterone timings on live birth rates for blastocyst frozen embryo transfer cycles","volume":"49","author":"Zhou","year":"2024","journal-title":"Reprod Biomed Online"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/41\/1\/86\/65231840\/deaf205.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/41\/1\/86\/65231840\/deaf205.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T05:52:06Z","timestamp":1767678726000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article\/41\/1\/86\/8315318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,5]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,11,5]]},"published-print":{"date-parts":[[2026,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/deaf205","relation":{},"ISSN":["0268-1161","1460-2350"],"issn-type":[{"value":"0268-1161","type":"print"},{"value":"1460-2350","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2025,11,5]]}}}